Pharmacokinetic changes of cyclosporine after intravenous and oral administration to rats with uranyl nitrate-induced acute renal failure

International Journal of Pharmaceutics

Volumn 194, Issue 2, 2000, Pages 221-227

  Lee, Yong Hwa ^a   Park, Kyoung Ho ^b   Ku, Young Soon ^a  

^a Ewha Womans University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Acute renal failures; Cyclosporine; Pharmacokinetics; Rats; Uranyl nitrate

Indexed keywords

CYCLOSPORIN A; URANYL NITRATE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; CYCLOSPORINE; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; MALE; RATS; RATS, SPRAGUE-DAWLEY; URANYL NITRATE;

EID: 0342545976     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00382-8     Document Type: Article

References (25)

1. Awni W.M., Sawchuk R.J. The pharmacokinetics of cyclosporine. I. Single dose and constant rate infusion studies in the rabbit. Drug Metab. Dispos. 13:1985;127-132.
2. Chiou W.L. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J. Pharmacokinet. Biopharm. 6:1978;539-546.
3. Chiou W.L. New calculation method for mean apparent drug volume of distribution and its application to rational regimens. J. Pharm. Sci. 68:1979;1067-1069.
4. Chiou W.L. New calculation method of mean total clearance of drugs and its application to dosage regimens. J. Pharm. Sci. 69:1980;90-91.
5. Cyclo-Trac®, 1995. SP-Whole Blood: Radioimmunoassay for Cyclosporine Instruction Manual, Incstar Corporation, Stillwater, MN.
6. Drewe J., Beglinger C., Kissel T. The absorption site of cyclosporine in the human gastrointestinal tract. Br. J. Clin. Pharmacol. 33:1992;39-43.
7. Eatman F.B., Colburn W.A., Boxenbaum H.G., Posmanter H.N., Weinfeld R.E., Ronfeld R., Weissman L., Moore J.D., Gibaldi M., Kaplan S.A. Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects. J. Pharmacokinet. Biopharm. 5:1977;481-494.
8. Fahr A. Cyclosporine clinical pharmacokinetics. Clin. Pharmacokinet. 24:1993;472-495.
9. Fruncillo R.J., Swanson B.N., Bernhard R., Marchion C., Ferguson R.K. Effect of renal failure or biliary stasis on the pharmacokinetics of amiodarone in the rat. J. Pharm. Sci. 75:1986;150-154.
10. Gibaldi M., Perrier D. Pharmacokinetics. 2nd edition:1982;Dekker, New York.
11. Hedayati S., Bernareggi A., Rowland M. Absorption kinetics of cyclosporine in the rat. J. Pharm. Pharmacol. 44:1992;122-124.
12. Itoh T., Sawada Y., Lin T.H., Iga T., Hanano M. Kinetic analysis of phenytoin disposition in rats with experimental renal and hepatic disease. J. Pharmacobiodyn. 11:1988;289-308.
13. Kim O.N. Pharmacokinetics of theophylline in experimental acute renal failure rats (I). Yakhak Hoeji. 35:1991;38-44.
14. Kim S.H., Choi Y.M., Lee M.G. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J. Pharmacokinet. Biopharm. 21:1993;1-17.
15. Kim Y.G., Yoon E.J., Yoon W.H., Shim H.J., Lee S.D., Kim W.B., Yang J., Lee M.G. Pharmacokinetics of DA-125, a new anthracycline, after intravenous administration to uranyl nitrate-induced acute renal failure rats or protein-calorie malnutrition rats. Biopharm. Drug Dispos. 17:1996;183-195.
16. Kim S.H., Shim H.J., Kim W.B., Lee M.G. Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure. Antimicrob. Agents Chemother. 42:1998;1217-1221.
17. Lee Y.-H., Lee M.-H., Shim C.-K. Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure. Pharm. Res. 9:1992;1599-1606.
18. Lee H.J., Paik W.H., Lee M.G. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats. Res. Commun. Mol. Pathol. Pharmacol. 91:1996;195-204.
19. Lindberg F.A., Karlsson M.O. Dose dependent absorption and linear disposition of cyclosporin A in rat. Biopharm. Drug Dispos. 15:1994;75-86.
20. Lindholm A. Factors influencing the pharmacokinetics of cyclosporine in man. Ther. Drug Monitor. 13:1991;465-477.
21. Park K.J., Yoon W.H., Kim S.H., Shin W.G., Lee M.G. Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration of azosemide to uranyl nitrate-induced acute renal failure rats. Biopharm. Drug Dispos. 19:1998;141-146.
22. Shibata N., Shimakawa H., Minouchi T., Yamaji A. Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states. Biol. Pharm. Bull. 16:1993;1130-1135.
23. Terao N., Shen D.D. Pharmacokinetics of l-propranolol during repetitive dosing in normal and uranyl nitrate-induced renal failure rats. J. Pharmacokinet. Biopharm. 12:1984;479-493.
24. Wagner O., Schreier E., Heitz F., Maurer G. Tissue distribution, disposition, and metabolism of cyclosporine in rats. Drug Metab. Dispos. 15:1987;377-383.
25. Wu C.Y., Benet L.Z., Hebert M.F., Gupta S.K., Rowland M., Gomez D.Y., Wacher V.J. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine. Clin. Pharmacol. Ther. 58:1995;492-497.